Apogee Therapeutics

Vice President, Inflammatory and Immune Disease Biomarker Development

Apogee Therapeutics

2 months ago
Hybrid
Full Time
Executive
2 applicants
View Job Listing
Apogee Therapeutics
Apply to 100+ jobs

About this role

Apogee Therapeutics is hiring a Vice President to lead biomarker development for inflammatory and immune diseases, with emphasis on atopic dermatitis, asthma, COPD, and EOE. The role reports to the SVP of Research and Translational Medicine and drives biomarker strategy across late-stage development through Phase 3 and BLA readiness. This leader will build and guide internal teams while managing external collaborators to advance biomarker programs that support clinical and regulatory goals.

Skills

Qualifications

PhDMD
Apogee Therapeutics

About Apogee Therapeutics

apogeetherapeutics.com

Apogee Therapeutics is a clinical-stage biotechnology company developing differentiated biologics for immunological and inflammatory diseases. The company focuses on high-unmet-need conditions including atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other I&I disorders. Apogee advances therapeutic candidates through clinical development with the goal of delivering best‑in‑class treatments for patients with inflammatory and immune-mediated diseases.

About Apogee Therapeutics

Headquarters

San Francisco, CA

Company Size

201-500 employees

Founded

2018

Industry

Technology

Glassdoor Rating

4.2 / 5

Leadership Team

Sarah Johnson

Chief Executive Officer

Michael Chen

Chief Technology Officer

Emily Williams

VP of Engineering

David Rodriguez

VP of Product

Jessica Thompson

Chief Financial Officer

Andrew Park

VP of Sales

Unlock Company Insights

View leadership team, funding history,
and employee contacts for Apogee Therapeutics.

Reveal Company Insights

ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

© All Rights Reserved. ApplyBlast.com